1)Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, China;2)The Second Clinical Medical College of Shanxi Medical University ,Taiyuan 030001, China;3)The First Clinical Medical College of Shanxi Medical University ,Taiyuan 030001, China;4)State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China
This work was supported by grants from The National Natural Science Foundation of China (22007062), The Innovation and Entrepreneurship Training Project for College Students in Shanxi Province (S2021101140230), the Shanxi Provincial Research Foundation for Basic Research (202103021224236), and Science Research Start-up Fund for Doctor of Shanxi Medical University (XD1911).
Objective To detect the active ingredients in the traditional Chinese medicine prescription and its molecular mechanisms against SARS-CoV-2 by prescription mining and molecular dynamics simulations.Methods Herein, prescription mining and virtual screening of drugs were performed to screen the potential inhibitors against SARS-CoV-2. Molecular docking and molecular dynamics (MDs) simulations were further performed to explore the molecular recognition and inhibition mechanism between the potential inhibitors and SARS-CoV-2.Results The natural compounds library was constructed by 143 prescriptions of traditional Chinese medicine, which contained 640 natural compounds. Ten compounds were screened out from the natural compounds library. Among the 10 compounds, 23-trans-p-coumaryhormentic acid, the main active constituent of the Loquat leaf, showed the best binding affinity targeting the recognizing interface of SARS-CoV-2 S protein/ACE2. Upon binding 23-trans-p-coumaryhormentic acid, the key interactions between SARS-CoV-2 S protein and ACE2 were almost interrupted.Conclusion Ten compounds targeting SARS-CoV-2 S protein/ACE2 interface were screened out from natural compound library. And we inferred that 23-trans-p-coumaryhormentic acid is a potential inhibitor against SARS-CoV-2, which would contribute to the development of the antiviral drug for SARS-CoV-2.
ZHANG Xiao-Zheng, GAO Ying, LIU Yu, TAI Yang-Hao, LIANG Li-Zhong, ZHANG Yu-Long, HOU Shu-Lin, XIE Jun. Screening of Potential Inhibitors Against SARS-CoV-2 Based on Prescription Mining and Molecular Dynamics Simulations[J]. Progress in Biochemistry and Biophysics,2022,49(10):1889-1900
Copy® 2025 All Rights Reserved ICP:京ICP备05023138号-1 京公网安备 11010502031771号